Ben Teply, MD

Assistant Professor

  • 3356 Citations
  • 11 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2004 2019

Filter
Review article
2017
13 Citations (Scopus)

Treatment strategies for DNA repair-deficient prostate cancer

Teply, B. A. & Antonarakis, E. S., Aug 3 2017, In : Expert Review of Clinical Pharmacology. 10, 8, p. 889-898 10 p.

Research output: Contribution to journalReview article

DNA Repair-Deficiency Disorders
Prostatic Neoplasms
DNA Repair
Neoplasms
Therapeutics
2016
8 Citations (Scopus)

Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer

Teply, B. A. & Antonarakis, E. S., Jun 1 2016, In : Current Opinion in Endocrinology, Diabetes and Obesity. 23, 3, p. 279-290 12 p.

Research output: Contribution to journalReview article

Castration
Androgens
Prostatic Neoplasms
Androgen Receptor Antagonists
Pharmaceutical Preparations
2014
43 Citations (Scopus)

Identification and management of toxicities from immune checkpoint-blocking drugs

Teply, B. A. & Lipson, E. J., Nov 1 2014, In : Oncology (Williston Park, N.Y.). 28, p. 30-38 9 p.

Research output: Contribution to journalReview article

Pharmaceutical Preparations
Practice Guidelines
Antineoplastic Agents
Neoplasms
Therapeutics
11 Citations (Scopus)

Systemic therapy for bladder cancer - a medical oncologist's perspective

Teply, B. A. & Kim, J. J., Jan 1 2014, In : Journal of Solid Tumors. 4, 2, p. 25-35 11 p.

Research output: Contribution to journalReview article

Urinary Bladder Neoplasms
Cisplatin
gemcitabine
Vinblastine
Methotrexate
2006
5 Citations (Scopus)

Nanoparticle-aptamer bioconjugates for targeted antineoplastic drug delivery

Teply, B. A., Rocha, F. G., Levy-Nissenbaum, E., Langer, R. & Farokhzad, O. C., Sep 12 2006, In : American Journal of Drug Delivery. 4, 3, p. 123-130 8 p.

Research output: Contribution to journalReview article

Antineoplastic Agents
Nanoparticles
docetaxel
Neoplasms
Pharmaceutical Preparations